Clever-1/PD-L1 ratio predicts response to Bexmarilimab, a novel macrophage-guided immunotherapy, in immune deprived cancersMari L. Bjorkman,Elisa M. Vuorinen,Juho Jalkanen,Marie-Louise Fjallskog,Jussi Koivunen,Teppo Huttunen,Maija Hollmen,Petri BonoCANCER RESEARCH(2023)引用 0|浏览22暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要